Make a Gift
Trinity Professorial Fellow Marta Kwiatkowska will be part of a major global initiative in pursuit of responsible artificial intelligence.
Professor Kwiatkoska was nominated by the European Commission and has been invited to join the Responsible AI Working Group of the Global Partnership on Artificial Intelligence (GPAI) initiative. The international initiative was formed to promote responsible AI grounded in human rights, inclusion, diversity, innovation, and economic growth.
The initiative will look to bridge the gap between theory and practice on AI by supporting cutting-edge research and applied activities on AI-related priorities. The GPAI brings together experts from industry, government, civil society and academia. The Partnership was conceived by Canada and France during their G7 presidencies and at its launch counted 13 other founding members, including the UK.
Professor Kwiatkowska has been recognised with numerous awards for her contribution to the field of computer sciences, including for her major contributions to probabilistic and quantitative model checking. She is currently leading European Research Council (ERC) Advanced Grant for a project that aims to make progress towards provably robust ‘strong’ artificial intelligence – which seeks to match human intelligence – amid rapid advancement in machine learning technology.
Professor Kwiatkowska said: ‘I am excited to be an expert participant of the Responsible AI Working Group for the Global Partnership on AI and look forward to progressing this important initiative. The topics of safety and robustness for AI are a focus of my current work, and are very important for the responsible deployment of AI systems.’
Please see this blog post for an update on our work, plus an opportunity to partner with us on a new tender!’
Congratulations to Professor Katherine Ibbett on her award of a one-year Leverhulme Research Fellowship to work on her latest book project.
Trinity’s current Senior Tutor Professor Valerie Worth will be stepping back from the role at the end of 2021.
Early treatment with inhaled budesonide shortens recovery time in certain patients with COVID-19, the latest trial led by Trinity Professorial Fellow Chris Butler has found.